Non allergic disorders associated with domestic moulds;Pathologie non allergique et exposition aux moisissures domestiques

Revue des Maladies Respiratoires

Volumn 27, Issue 2, 2010, Pages 180-187

  Palot, A ^a,b   Charpin Kadouch, C ^a   Dumon, H ^c   Charpin, D ^a,b  

^a HÔPITAL NORD   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Lab de parasitologie et de mycologie de l'environnement   (France)

Author keywords

Bacteria; Endotoxins; Environment; Glucans; Health; Humidity; Moulds; Mycotoxins

Indexed keywords

GLUCAN; MYCOTOXIN;

AIR POLLUTION; ALLERGY; AMBIENT AIR; ARTICLE; ASTHMA; BRONCHUS DISEASE; BUILDING; CHRONIC OBSTRUCTIVE LUNG DISEASE; EAR NOSE THROAT DISEASE; FEVER; FINANCIAL MANAGEMENT; HUMAN; LONG TERM EXPOSURE; LUNG HEMORRHAGE; MOULD; NEOPLASM; NEUROPSYCHIATRY; RESIDENTIAL HOME; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; RISK FACTOR; SINUSITIS;

EID: 77949541657     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmr.2009.09.006     Document Type: Short Survey

References (54)

1. Charpin D, Jacquot A, Charpin-Kadouch C. Prevalence and risk factors for damp housing: Results from the French 2002 Housing Survey. Direction des Statistiques Démographiques et Sociales. Document no. F0703. Institut national de la statistique et des études économiques; 2006.
2. Grille de visite des immeubles susceptibles d'̂tre déclarés insalubres. Conseil supérieur d'hygiène publique de France, Direction générale de la santé, 13 février 2003. http://www.sante.gouv.fr.
3. D'Halewyn MA, Leclerc JM, King N, et al. Les risques à la santé associés à la présence de moisissures en milieu intérieur. Institut national de santé publique du Québec, 2004. http://www.inspq.pq.ac.
4. Rylander R, Nordhall M, Engdahl U, Tunsater A, Holt PG. Airways inflammation, atopy, and 1-3-beta-D-glucan exposures in two schools. Am J Respir Crit Care Med 1998;158:1685-7.
5. Pasanen AL. A review: Fungal exposure assessment in indoor environments. Indoor Air 2001;11:87-98.
6. Parat S. Mesure de l'aérocontamination dans les bâtiments des secteurs résidentiel et tertiaire : état des connaissances et pratiques. Rapport ADEME. 2002.
7. Wessen B, Ström G, Palmgren U. Microbial problem in buildingsanalysis and verification. In: Proceedings of Indoor Air 99, Edinburgh, the 8th International Conference on Indoor Air Quality and Climate, Vol. 4. 1999. p.875-9.
8. Schleibinger H, Laussmann D, Bornehag CG, Eis D, Rueden H. Microbial volatile organic compounds in the air of moldy and mold-free indoor environments. Indoor Air 2008;18:113-24.
9. Smith TA, Lumley KP. Work-related asthma in a population exposed to grain, flour and other ingredient dusts. Occup Med (Lond) 1996;46:37-40.
10. Johanning E, Landsbergis P, Gareis M, Yang CS, Olmsted E. Clinical experience and results of a Sentinel Health Investigation related to indoor fungal exposure. Environ Health Perspect 1999;107:489-94.
11. Wan GH, Li CS. Dampness and airway inflammation and systemic symptoms in office building workers. Arch Environ Health 1999;54:58-63.
12. Pitt JI. Toxigenic fungi. Which are important? Med Mycol 2000;387:17-22.
13. Nielsen KF, Gravesen S, Nielsen PA, Andersen B, Thrane U, Frisvad JC. Production of mycotoxins on artificially and naturally infested building materials. Mycopathologia 1999;145: 43-56.
14. Page EH, Trout DB. The Role of Stachybotrys mycotoxins in building-related illness. AIHAJ 2001;62:644-8.
15. Wang H, Yadav JS. DNA damage, redox changes, and associated stress-inductible signaling events underlying the apoptosis and cytotoxicity in murine alveolar macrophage cell line MH-S by methanol-extracted Stachybotrys chartarum toxins. Toxicol Appl Pharmacol 2006;214:297-308.
16. Wang H, Yadav JS. Global gene expression changes underlying Stachybotrys chartarum toxin-induced apoptosis in murine alveolar macrophages: evidence of multiple signal transduction pathways. Apoptosis 2007;12:535-48.
17. Hendry KH, Cole EC. A review of mycotoxins in indoor air. J Toxicol Environ Health 1993;38:183-98.
18. Sorenson WG, Frazer DG, Jarvis BB, Simpson J, Robinson VA. Trichothecene mycotoxins in aerosolized conidia of Stachybotrys atra. Appl Environ Microbiol 1987;53:1370-5.
19. Etzel RA. Mycotoxins. JAMA 2002;287:425-7.
20. Seltzer JM. Building-related illnesses. J Allergy Clin Immunol 1994;94:351-61.
21. Autrup JL, Schmidt J, Autrup H. Exposure to aflatoxin B1 in animal-feed production plant workers. Environ Health Perspect 1993;99:195-7.
22. Marasas WFO, Nelson PE. Mycotoxicology. Pennsylvania State: University Press; 1984, 99 p.
23. Maheux L. Session on microbial contamination. Occupational and environmental health services agency. Health Canada; 1998. 55 p.
24. Pasanen AL, Keinanen J, Kalliokoski P, Martikainen PI, Ruuskanen J. Microbial growth on respirator filters from improper storage. Scand J Work Environ Health 1993;19: 421-5.
25. Grove JF. Non-macrocylic trichothecenes. Nat Prod Rep 1998;5:187-209.
26. Nielsen KF, Thrane U, Larsen TO, Nielsen PA, Gravesen S. Production of mycotoxins on artificially inoculated building materials. Int Biodet Biodegr 1998;42: 8-17.
27. Hinkley SF, Mazzola EP, Fettinger JC, Lam YF, Jarvis BB. Atranones A-G, from the toxigenic mold Stachybotrys chartarum. Phytochemistry 2000;55:663-73.
28. Jarvis BB, Salemme J, Morais A. Stachybotrys toxins. Nat Toxins 1995;3:10-6.
29. Jarvis BB. Stachybotrys chartarum: a fungus for our time. Phytochemistry 2003;64:53-60.
30. Vesper SJ, Magnuson ML, Dearborn DG, Yike I, Haugland RA. Initial characterization of the hemolysin stachylysin from Stachybotrys chartarum. Infect Immunol 2001;69: 912-6.
31. Johanning E, Gareis M, Nielsen K, Dietrich R, Martlbauer E. Airborne mycotoxin sampling and screening analysis. Indoor Air 2002.
32. Touomi T, Reijula K, Johnsson T, et al. Mycotoxins in crude building materials from water-damaged buildings. Appl Environ Microbiol 2000;66:1899-904.
33. Charpin-Kadouch C, Mouche JM, Quéralt J, et al. Mycotoxin identification in moldy dwellings. J Appl Toxicol 2006;26:475-9.
34. Emon V, Reed AW, Yike I, Vesper SJ. ELISA measurement of stachylysin in serum to quantify human exposures to the indoor mold Stachybotrys chartarum. J Occup Environ Med 2003;45:582-91.
35. Vojdani A, Campbell AW, Kashanian A, Vojdani E. Antibodies against molds and mycotoxins following exposure to toxigenic fungi in a water-damaged building. Arch Environ Health 2003;58:324-36.
36. Bloom E, Grimsley LF, Pehson C, Lewis J, Larsson L. Molds and mycotoxins in dust from water-damaged homes on New-Orleans after hurricane Katrina. Indoor Air 2009;19: 153-8.
37. Robbins CA, Swenson LJ, Neally ML, Gots RE, Kelman BJ. Health effects of mycotoxins in indoor air: a critical review. Appl Occup Environ Hyg 2000;15:773-84.
38. Vesper SJ, Vesper MJ. Stachylysin may be a cause of hemorrhaging in humans exposed to Stachybotrys chartarum. Infect Immun 2002;70:2065-9.
39. Johanning E, Landsbergis P, Gareis M, Yang CS, Olmsted E. Clinical experience and results of a sentinel health investiga tion related to indoor fungal exposure. Environ Health Perspect 1999;107:489-94.
40. Institute of Medicine of the National Academies. Damp indoor spaces and health. Washington D.C.: The National Academies Press; 2004.
41. Fisk WJ, Lei-Gomez Q, Mendell MJ. Meta-analyses of the associations of respiratory health effects with dampness and mold in homes. Indoor Air 2007;17:284-96.
42. Karvala K, Nordman H, Luukkonen R, et al. Occupational rhinitis in damp and moldy workplaces. Am J Rhinol 2008;22:457-62.
43. Sahakian NM, White SK, Park JH, et al. identification of mold and dampness-associated respiratory morbidity in 2 schools: comparison of questionnaire survey responses to national data. J Sch Health 2008;78:32-7.
44. Park JH, Cox-Ganser JM, Kreiss K, et al. Hydrophilic fungi and ergosterol associated with respiratory illness in a water-damaged building. Environ Health Perspect 2008;116: 45-50.
45. Cassimos CD, Chryssanthopoulos C, Panagiotidou C. Epidemiologic observations in idiopathic pulmonary hemosiderosis. J Pediatr 1983;102:698-702.
46. Montana E, Etzel RA, Allan T, Horgan TE, Dearborn DG. Environmental risk factors associated with pediatric idiopathic pulmonary hemorrhage and hemosiderosis in a Cleveland community. Pediatrics 1997;99:E5.
47. Etzel RA. Indoor and outdoor air pollution: tobacco smoke, moulds and diseases in infants and children. Int J Hyg Environ Health 2007;210:611-6.
48. Committee on Environmental Health, American Academy of Pediatrics. Spectrum of non-infectious health effects from molds. Pediatrics 2006;118:1909-26.
49. Sahakian N, Park JH, Cox-Ganser J. Respiratory morbidity and medical visits associated with dampness and air-conditioning in offices and homes. Indoor Air 2009;19: 58-67.
50. Perez-Uribe A, Molina de Soschin D, Arenas R, Reyes M. Primary cutaneous mucormycosis. Report of a case in a HIV patient. Rev Iberoam Micol 2005;22:118-21.
51. Saadat P, Kappel S, Young S, et al. Aspergillus fumigatus Majocchi's granuloma in a patient with acquired immunodeficiency syndrome. Clin Exp Dermatol 2008;33:453-540.
52. Oiu-Xia C, Chano-Xing L, Wen-Ming H, et al. Subcutaneous phaeohyphomycosis caused by Cladosporium sphaerospermum. Mycoses 2008;51:79-80.
53. Groupe de travail « Moisissures de l'habitat ». Conseil supérieur d'hygiène publique de France, 2005. http://www.sante. gouv.fr.
54. Goh JC, Riggs MA, Chew GL, et al. Characterisation of airborne molds, endotoxins, and glucans in homes in New-Orleans after Hurricanes Katrina and Rita. Appl Environ Microbiol 2007;73:1630-4.